Table 2.

Cox proportional hazard model of all-cause mortality (event 88, n = 552).

Risk factor	Univariable			Multivariable
	HR	95% CI	P-value	HR	95% CI	P-value
PRECISE-DAPT score (low)	Ref.			Ref.
Intermediate (vs. low)	3.161	1.309–7.630	<0.001	2.945	1.182–7.237	0.020
High (vs. low)	7.246	3.614–14.527	<0.001	5.567	2.644–11.721	<0.001
Male gender	0.832	0.514–1.349	0.456
Body mass index	0.899	0.844–0.959	0.001	0.989	0.922–1.061	0.759
Current smoker	0.568	0.373–0.864	0.008	0.940	0.590–1.497	0.793
Hypertension	1.040	0.499–2.167	0.917
Diabetes	1.042	0.686–1.584	0.846
Dyslipidemia	0.262	0.138–0.497	<0.001	1.186	0.498–2.825	0.701
Atrial fibrillation	2.701	1.686–4.327	<0.001	2.491	1.381–4.490	0.002
Previous MI	1.539	0.772–3.067	0.221
Previous PCI	1.203	0.603–2.399	0.599
Previous CABG	1.317	0.183–9.477	0.785
LVEF	0.985	0.975–0.994	0.002	0.988	0.977–1.000	0.049
Number of diseased vessels	1.411	0.921–2.163	0.114
No-infarct LMT lesion	1.993	0.918–4.327	0.081	1.592	0.712–3.557	0.257
No-infarct CTO lesion	2.743	1.615–4.659	<0.001	2.477	1.387–4.423	0.002
Culprit lesion (LAD)	0.778	0.506–1.195	0.252
Log peak CK	0.924	0.577–1.481	0.744
DES	0.932	0.605–1.436	0.750
BMS	0.737	0.463–1.174	0.199
Door to balloon time	1.002	0.999–1.004	0.154
Antiplatelets	0.215	0.093–0.494	<0.001	0.231	0.074–0.726	0.012
β-blockers	0.622	0.388–0.995	0.047	0.796	0.473–1.340	0.390
RAS inhibitors	0.491	0.289–0.835	0.009	0.551	0.303–1.001	0.051
Statins	0.249	0.159–0.390	<0.001	0.483	0.263–0.890	0.020
Anticoagulants	1.562	0.977–2.498	0.062	0.877	0.497–1.550	0.652

PRECISE-DAPT, the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy; MI, myocardial infarction; PCI, percutaneous coronary intervention; CABG, coronary artery bypass graft; LVEF, left ventricular ejection fraction; LMT, left main trunk; CTO, chronic total occlusion; LAD, left anterior descending coronary artery; CK, creatine kinase; DES, drug eluting stent; BMS, bare metal stent; RAS, renin-angiotensin system.